Loading…
Underlying
Underlying Price
$8.28
Type
Put
Strike
10.5
Expiration
Oct 30, 2026
DTE
10d
Moneyness
ITM
Intrinsic
$2.22
IBRX 10.5 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3d | $0.89 | +18.67% | 12 | 38 |
| Oct 30, 2026 | 10d | $1.32 | +7.32% | 1 | 54 |
| Nov 6, 2026 | 17d | $1.17 | -29.94% | 1 | 20 |
| Nov 13, 2026 | 24d | $1.60 | +39.13% | 23 | 33 |
| Nov 27, 2026 | 38d | $1.87 | +24.67% | 4 | 7 |
IBRX Nearby Strikes · Oct 30, 2026
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.